TP53 and neoplasm: Interestingly, despite the antiangiogenic activity of DIMP53‐1 in an in vitro endothelial cell system (without tumor cells), the results obtained in vivo showed that this antiangiogenic effect is highly dependent on tumor environment, particularly of the p53 status in these tumors.